0001478448-24-000001.txt : 20240209 0001478448-24-000001.hdr.sgml : 20240209 20240209160504 ACCESSION NUMBER: 0001478448-24-000001 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240209 DATE AS OF CHANGE: 20240209 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: IRONWOOD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001446847 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 043404176 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-34620 FILM NUMBER: 24614705 BUSINESS ADDRESS: STREET 1: 100 SUMMER STREET, SUITE 2300 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-621-7722 MAIL ADDRESS: STREET 1: 100 SUMMER STREET, SUITE 2300 CITY: BOSTON STATE: MA ZIP: 02110 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Davis Andrew CENTRAL INDEX KEY: 0001932525 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 100 SUMMER STREET STREET 2: SUITE 2300 CITY: BOSTON STATE: MA ZIP: 02110 144 1 primary_doc.xml 144 0001932525 XXXXXXXX LIVE 0001446847 IRONWOOD PHARMACEUTICALS INC 001-34620 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722 Davis Andrew Officer Class A Common Stock E Trade Securities LLC

3 Edison Drive Alpharetta GA 30005

11519 171633.10 156129046 02/12/2024 Nasdaq Class A Common Stock 02/24/2022 Restricted Stock Unit award granted pursuant to Issuer's 2019 Equity Incentive Plan, subject to vesting requirements Ironwood Pharmaceuticals, Inc. N 9842 02/24/2022 N/A Class A Common Stock 03/08/2023 Restricted Stock Unit award granted pursuant to Issuer's 2019 Equity Incentive Plan, subject to vesting requirements Ironwood Pharmaceuticals, Inc. N 18559 03/08/2023 N/A N Andrew Davis

100 Summer Street Suite 2300 Boston MA 02110

Class A Common Stock 11/20/2023 3287 31851.03 Shares sold to cover taxes from the vesting of stock awards granted by the Issuer. 02/09/2024 /s/ Andrew Davis